CS211364B2 - Method of making the oxymorfone - Google Patents

Method of making the oxymorfone Download PDF

Info

Publication number
CS211364B2
CS211364B2 CS797115A CS711579A CS211364B2 CS 211364 B2 CS211364 B2 CS 211364B2 CS 797115 A CS797115 A CS 797115A CS 711579 A CS711579 A CS 711579A CS 211364 B2 CS211364 B2 CS 211364B2
Authority
CS
Czechoslovakia
Prior art keywords
mixture
boron compound
reaction
oxycodone
hours
Prior art date
Application number
CS797115A
Other languages
Czech (cs)
English (en)
Inventor
Michael L Wilson
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of CS211364B2 publication Critical patent/CS211364B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polarising Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS797115A 1978-10-19 1979-10-19 Method of making the oxymorfone CS211364B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95305678A 1978-10-19 1978-10-19

Publications (1)

Publication Number Publication Date
CS211364B2 true CS211364B2 (en) 1982-02-26

Family

ID=25493512

Family Applications (1)

Application Number Title Priority Date Filing Date
CS797115A CS211364B2 (en) 1978-10-19 1979-10-19 Method of making the oxymorfone

Country Status (16)

Country Link
JP (1) JPS55501025A (fr)
AU (1) AU5189779A (fr)
BE (1) BE879494A (fr)
CA (1) CA1108132A (fr)
CS (1) CS211364B2 (fr)
DK (1) DK258280A (fr)
ES (1) ES485154A1 (fr)
FI (1) FI793235A (fr)
FR (1) FR2439201A1 (fr)
GB (1) GB2049680A (fr)
IL (1) IL58489A0 (fr)
IT (1) IT7969032A0 (fr)
NL (1) NL7920126A (fr)
NO (1) NO793297L (fr)
SE (1) SE8004454L (fr)
WO (1) WO1980000841A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5668285A (en) * 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
FR2636330B1 (fr) * 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
ES2129395T3 (es) * 1989-10-16 1999-06-16 Us Health Sintesis total de enantiomeros de nortebaina, normorfina, noroximorfona y sus derivados a traves de productos intermedios n-nor.
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
EP1414458B1 (fr) 2001-07-06 2007-04-11 Endo Pharmaceuticals Inc. Administration orale de 6-hydroxy-oxymorphone utilise en tant qu'analgesique
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP5695296B2 (ja) 2006-03-02 2015-04-01 マリンクロッド エルエルシー 低レベルのアルファ,ベータ−不飽和ケトン化合物を伴うモルフィナン−6−オン生成物の製造方法
JP5774853B2 (ja) 2008-01-25 2015-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 医薬投薬形
TWI524904B (zh) 2008-05-09 2016-03-11 歌林達股份有限公司 製備醫藥用固體劑型,尤指錠劑之方法,及製備固體劑型,尤指錠劑之前驅物之方法
JP2012533586A (ja) 2009-07-22 2012-12-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 酸化安定化された不正使用防止剤形
CA2765971C (fr) 2009-07-22 2017-08-22 Gruenenthal Gmbh Forme galenique extrudee a chaud a liberation controlee
NZ608865A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising an anionic polymer
AU2011297901B2 (en) 2010-09-02 2014-07-31 Grunenthal Gmbh Tamper resistant dosage form comprising inorganic salt
PT2736497T (pt) 2011-07-29 2017-11-30 Gruenenthal Gmbh Comprimido resistente a adulteração proporcionando libertação imediata de fármaco
CN103841964A (zh) 2011-07-29 2014-06-04 格吕伦塔尔有限公司 提供药物立即释放的抗破碎片剂
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
WO2013156453A1 (fr) 2012-04-18 2013-10-24 Grünenthal GmbH Forme pharmaceutique inviolable et résistante à la libération massive
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
CA2913209A1 (fr) 2013-05-29 2014-12-04 Grunenthal Gmbh Forme dosifiee inviolable a profil de liberation bimodale
MX368846B (es) 2013-07-12 2019-10-18 Gruenenthal Gmbh Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
EP3073994A1 (fr) 2013-11-26 2016-10-05 Grünenthal GmbH Préparation de composition pharmaceutique en poudre par cryo-broyage
EP3142646A1 (fr) 2014-05-12 2017-03-22 Grünenthal GmbH Formulation pour capsule à libération immédiate résistant aux manipulations illicites comprenant du tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
EA035434B1 (ru) 2015-04-24 2020-06-15 Грюненталь Гмбх Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
EP3346991A1 (fr) 2015-09-10 2018-07-18 Grünenthal GmbH Protection contre un surdosage par voie orale à l'aide de formulations à libération immédiate dissuasives d'abus
ES2701855T3 (es) 2016-05-31 2019-02-26 Alcaliber Investig Desarrollo E Innovacion Slu Proceso para la obtención de 3,14-diacetiloximorfona a partir de oripavina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249616A (en) * 1966-05-03 Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof
US2806033A (en) * 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives

Also Published As

Publication number Publication date
FR2439201A1 (fr) 1980-05-16
AU5189779A (en) 1980-04-24
FI793235A (fi) 1980-04-20
WO1980000841A1 (fr) 1980-05-01
GB2049680A (en) 1980-12-31
IT7969032A0 (it) 1979-10-18
CA1108132A (fr) 1981-09-01
JPS55501025A (fr) 1980-11-27
NO793297L (no) 1980-04-22
BE879494A (fr) 1980-02-15
DK258280A (da) 1980-06-17
SE8004454L (sv) 1980-06-16
ES485154A1 (es) 1980-06-16
NL7920126A (nl) 1980-08-29
IL58489A0 (en) 1980-01-31

Similar Documents

Publication Publication Date Title
CS211364B2 (en) Method of making the oxymorfone
CA2040927C (fr) Procede de fabrication de sucrose-6-ester
IE911343A1 (en) Process for recovery of organotin esters from reaction mixtures containing the same and re-use of the recovered organotin compounds
JPH0212478B2 (fr)
CN1015104B (zh) 烯丙基酯类和醚类的脱保护方法
EP0079447B1 (fr) Dérivés de déazapurine
US5256793A (en) Triazolinone ring formation in tert-butanol
US6049014A (en) Process for the manufacture of tetrabromobisphenol-A with co-production of n-propyl bromide
EP0327473A2 (fr) Procédé de préparation de métaborate d'aryle et son application à la préparation des alcools orthohydroxybenzyliques
JP3446899B2 (ja) ハロピリジル−アザビシクロヘプタン誘導体の製造法および中間体
US5162570A (en) Process for producing 1,4-dihydroxy-2-arylnaphthoate
US5241103A (en) Process for producing 1,4-dihydroxy-2-arylnaphthoate
US5157156A (en) Process for preparing an intermediate useful in the syntheis of probucol
EP0297783B1 (fr) Méthode de préparation de 4-alcoxyppyridine-1-oxides
CA1290754C (fr) Methode de fabrication des derives de benzoguanamine
Hart et al. Semi-synthesis and insecticidal activity of dyshomoerythrine derivatives
CA1134839A (fr) Preparation de 5-hydroxymethylimidazoles
US4709059A (en) Process for selective halogenation of primary hydroxyl groups
EP0062068B1 (fr) Derives de n-phthalidyl-5-fluorouracile
EP0319960B1 (fr) Dérivé d'imidazole
EP0222172A2 (fr) Dérivé de l'acide N-glycolylneuraminique
EP0524959B1 (fr) Procede d'obtention d'un intermediaire de sultamicilline
KR900008126B1 (ko) 할로겐화 페놀-알데히드 축합생성물 유도체의 제조방법
US20040034213A1 (en) Process for producing a ribofuranose
EP0074837A1 (fr) Pyridines 4-substitués comme catalyseurs